Clinical trial NCT03593603: Trending of Respiratory Rate Using the Nellcor™ Bedside Respiratory Patient Monitoring System
Official title: An Evaluation of Plethysmography-based Trending of Respiratory Rate Using the Nellcor™ Bedside Respiratory Patient Monitoring System
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Patients Prescribed Non-invasive Respiratory Monitoring
Lead sponsor: Medtronic - MITG
Sponsor class: INDUSTRY
First posted: 2018-07-20
Enrollment: 37
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients will be included who provide informed consent, who are prescribed non-invasive respiratory monitoring via spot check vital signs at least every 4 hours and are without any contact skin allergies to adhesives found in standard pulse oximetry sensors. Potential subjects are those who will be admitted to the General Care Floor. The subject pool will be approximately divided equally between medical/non-surgical and surgical patients.

Brief summary: This is an open-label, non-randomized, prospective, descriptive study of the Nellcor™ Bedside Respiratory Patient Monitoring System using the Nellcor™ Respiration Rate parameter and Nellcor™ Adult Respiratory Sensor The study is intended to gain further information in the clinical space on the function of the Nellcor™ Respiration Rate parameter. The primary objective is to describe spot check (e.g. manual observation) of respiration rate versus cumulative automated counting (trend) of respiratory rate as measured using the Nellcor™ Bedside Respiratory Patient Monitoring System with the Nellcor™ Respiration Rate parameter.


Eligibility criteria: Inclusion Criteria:

1. 18 years or older.
2. A patient who meets the weight requirement for the sensor (e.g. \>30kg).
3. A patient at the study site on a General Care Floor (surgical or medical/non-surgical to be distributed equally) and prescribed standard vital sign checks.
4. Patient is willing and able to provide written informed consent.

Exclusion Criteria:

1. Expected length of stay is \< 4 hours.
2. Patient is pregnant or lactating.
3. Patient has severe contact allergies that may cause a reaction to standard adhesive materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or other medical sensors.
4. Patient has an abnormality that may prevent proper application of the device.
5. Patient is in atrial fibrillation.
6. Patient has a documented history of frequent premature atrial contractions (PACs) or premature ventricular contractions (PVCs), defined as greater than 3 in 30 seconds or greater than 6 in 60 seconds within the past 3 months.
7. Patient has an implanted pacemaker.
8. Patient has excessive nail polish that cannot be removed or other dye or discoloration of the finger.
9. Patient has diagnosed central apnea or diagnosed significant obstructive sleep apnea.
10. Patient is currently using continuous positive airway pressure (CPAP).
11. Patient is unwilling or unable to sign informed consent.
12. Evidence that the patient cannot understand the purpose and risks of the study and would require a legally authorized representative to sign informed consent.
13. Patient is participating in another potentially confounding clinical study.
14. Extreme motion conditions such as patient is prescribed to walk more than once per hour or is prescribed a medical device resulting in constant movement.

Primary outcomes:
measure: Agreement of RR measured by spot checks vs continuous monitoring
timeFrame: at least 4 hours
Secondary outcomes:
Other outcomes:
Locations:
city: Tulsa
country: United States
facility: St. John Health System
state: Oklahoma
city: Tacoma
country: United States
facility: MultiCare Institute for Research & Innovation
state: Washington
Study officials:
affiliation: MultiCare Institute for Research and Innovation
name: Paul J Amoroso, MD
role: PRINCIPAL_INVESTIGATOR
References: